Watson begins distribution of generic Pravachol

By Lisa Kerner

Erie, Pa., April 25 - Watson Pharmaceuticals, Inc., under a distribution agreement with Bristol-Myers Squibb Co., started shipments of pravastatin sodium tablets in the 10 mg, 20 mg and 40 mg strengths.

Pravastatin sodium is the generic version of Bristol-Myers Squibb's Pravachol product to reduce the risk of first heart attack in patients with elevated cholesterol and recurrent heart attack or a stroke in patients with heart disease, according to a news release.

For the 12 months ended Dec. 31, Pravachol sales reached about $1.7 billion, according to IMS Health data.

Watson is a specialty pharmaceutical company located in Corona, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.